Millennium Biotechnologies, Inc. Completes Recapitalization and Receives New Financing

Published: Nov 16, 2009

BASKING RIDGE, N.J., Nov. 16, 2009 (GLOBE NEWSWIRE) -- Millennium Biotechnologies, Inc. a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTCBB:MBTG), a leader in the development, manufacturing and sales of targeted nutritional products in the Clinical and Sports Nutrition Markets, announced today that it has completed a recapitalization and elimination of over $14,000,000 of the current liabilities.

Back to news